Asymptomatic atrial fibrillation burden and thromboembolic events: piecing evidence together

References

• Chen-Scarabelli C, Scarabelli TM, Ellenbogen KA, et al. Device-detected atrial fibrillation: what to do with asymptomatic patients? J Am Coll Cardiol. 2015;65(3):281–294. doi:10.1016/j.jacc.2014.10.045.
   PubMed Web of Science ®Google Scholar
• Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478–2486. doi:10.1056/NEJMoa1313600.
   PubMed Web of Science ®Google Scholar
• Gladstone DJ, Spring M, Dorian P, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370(26):2467–2477. doi:10.1056/NEJMoa1311376.
   PubMed Web of Science ®Google Scholar
• Steinberg BA, Hellkamp AS, Lokhnygina Y, et al. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. Eur Heart J. 2015;36(5):288–296. doi:10.1093/eurheartj/ehu359.
   PubMed Web of Science ®Google Scholar
• Vanassche T, Lauw MN, Eikelboom JW, et al. Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. Eur Heart J. 2015;36(5):281–7a. doi:10.1093/eurheartj/ehu307.
   PubMed Web of Science ®Google Scholar
• Purerfellner H, Gillis AM, Holbrook R, et al. Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies. Pacing Clin Electrophysiol. 2004;27(7):983–992. doi:10.1111/j.1540-8159.2004.00569.x.
   PubMed Web of Science ®Google Scholar
• Passman RS, Weinberg KM, Freher M, et al. Accuracy of mode switch algorithms for detection of atrial tachyarrhythmias. J Cardiovasc Electrophysiol. 2004;15(7):773–777. doi:10.1046/j.1540-8167.2004.03537.x.
   PubMed Web of Science ®Google Scholar
• Verma A, Cairns JA, Mitchell LB, et al. 2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation. Can J Cardiol. 2014;30(10):1114–1130. doi:10.1016/j.cjca.2014.08.001.
   PubMed Web of Science ®Google Scholar
• Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366(2):120–129. doi:10.1056/NEJMoa1105575.
   PubMed Web of Science ®Google Scholar
• Boriani G, Glotzer TV, Santini M, et al. Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices). Eur Heart J. 2014;35(8):508–516. doi:10.1093/eurheartj/eht491.
   PubMed Web of Science ®Google Scholar
• Macle L, Cairns JA, Andrade JG, et al. The 2014 atrial fibrillation guidelines companion: a practical approach to the use of the Canadian Cardiovascular Society guidelines. Can J Cardiol. 2015;31(10):1207–1218. doi:10.1016/j.cjca.2015.06.005.
   PubMed Web of Science ®Google Scholar
• Senn SJ. Overstating the evidence: double counting in meta-analysis and related problems. BMC Med Res Methodol. 2009;9:10. doi:10.1186/1471-2288-9-10.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
   PubMedGoogle Scholar
• Alhadramy O, Jeerakathil TJ, Majumdar SR, et al. Prevalence and predictors of paroxysmal atrial fibrillation on Holter monitor in patients with stroke or transient ischemic attack. Stroke. 2010;41(11):2596–2600. doi:10.1161/STROKEAHA.109.570382.
   PubMed Web of Science ®Google Scholar
• Al-Khatib SM, Thomas L, Wallentin L, et al. Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. Eur Heart J. 2013;34(31):2464–2471. doi:10.1093/eurheartj/eht135.
   PubMed Web of Science ®Google Scholar
• Bissinger A, Witkowski M, Lubinski A. Episodes of atrial fibrillation in pacemaker recipients. Exp Clin Cardiol. 2014;20(8):131–139.
   Google Scholar
• Brambatti M, Connolly SJ, Gold MR, et al. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation. 2014;129(21):2094–2099. doi:10.1161/CIRCULATIONAHA.113.007825.
   PubMed Web of Science ®Google Scholar
• Daoud EG, Glotzer TV, Wyse DG, et al. Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS. Heart Rhythm Off J Heart Rhythm Soc. 2011;8(9):1416–1423. doi:10.1016/j.hrthm.2011.04.022.
   PubMed Web of Science ®Google Scholar
• Karthikeyan G, Ananthakrishnan R, Devasenapathy N, et al. Transient, subclinical atrial fibrillation and risk of systemic embolism in patients with rheumatic mitral stenosis in sinus rhythm. Am J Cardiol. 2014;114(6):869–874. doi:10.1016/j.amjcard.2014.06.016.
   PubMed Web of Science ®Google Scholar
• Marfella R, Sasso FC, Siniscalchi M, et al. Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients. J Am Coll Cardiol. 2013;62(6):525–530. doi:10.1016/j.jacc.2013.02.091.
   PubMed Web of Science ®Google Scholar
• Ricci RP. Disease management: atrial fibrillation and home monitoring. Europace. 2013;15(Suppl 1):i35–i9. doi:10.1093/europace/eut114.
   Google Scholar
• Wang S-H, Kang Y-C, Wang -C-C, et al. Annual atrial tachyarrhythmia burden determined by device interrogation in patients with cardiac implanted electronic devices is associated with a risk of ischaemic stroke independent of known risk factors. Eur J Cardio-Thoracic Surg. 2015;47(5):840–846. doi:10.1093/ejcts/ezu252.
   PubMed Web of Science ®Google Scholar
• Winkle RA, Mead RH, Engel G, et al. Atrial arrhythmia burden on long-term monitoring in asymptomatic patients late after atrial fibrillation ablation. Am J Cardiol. 2012;110(6):840–844. doi:10.1016/j.amjcard.2012.05.012.
   PubMed Web of Science ®Google Scholar
• Ziegler PD, Glotzer TV, Daoud EG, et al. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention. Am J Cardiol. 2012;110(9):1309–1314. doi:10.1016/j.amjcard.2012.06.034.
   PubMed Web of Science ®Google Scholar
• Boriani G, Santini M, Lunati M, et al. Improving thromboprophylaxis using atrial fibrillation diagnostic capabilities in implantable cardioverter-defibrillators: the multicentre Italian ANGELS of AF project. Circ Cardiovasc Qual Outcomes. 2012;5(2):182–188. doi:10.1161/CIRCOUTCOMES.111.964205.
   PubMed Web of Science ®Google Scholar
• Botto GL, Padeletti L, Santini M, et al. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol. 2009;20(3):241–248. doi:10.1111/j.1540-8167.2008.01320.x.
   PubMed Web of Science ®Google Scholar
• Capucci A, Santini M, Padeletti L, et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol. 2005;46(10):1913–1920. doi:10.1016/j.jacc.2005.07.044.
   PubMed Web of Science ®Google Scholar
• Glotzer TV, Daoud EG, Wyse DG, et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythmia Electrophysiol. 2009;2(5):474–480. doi:10.1161/CIRCEP.109.849638.
   PubMed Web of Science ®Google Scholar
• Glotzer TV, Hellkamp AS, Zimmerman J, et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation. 2003;107(12):1614–1619. doi:10.1161/01.CIR.0000057981.70380.45.
   PubMed Web of Science ®Google Scholar
• Shanmugam N, Boerdlein A, Proff J, et al. Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population. Europace. 2012;14(2):230–237. doi:10.1093/europace/eur293.
   PubMed Web of Science ®Google Scholar
• Wasmer K, Eckardt L. Management of atrial fibrillation around the world: a comparison of current ACCF/AHA/HRS, CCS, and ESC guidelines. Europace. 2011;13(10):1368–1374. doi:10.1093/europace/eur172.
   PubMed Web of Science ®Google Scholar
• Verma A, Cairns JA, Mitchell LB, et al. 2014 Focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation. Can J Cardiol. 2014;30(10):1114–1130. doi:10.1016/j.cjca.2014.08.001.
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1–76. doi:10.1016/j.jacc.2014.03.022.
   PubMed Web of Science ®Google Scholar
• Camm AJ, Lip GY, De Caterina R, et al. 2012 Focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21):2719–2747.
   PubMed Web of Science ®Google Scholar
• Turakhia MP, Ziegler PD, Schmitt SK, et al. Atrial fibrillation burden and short-term risk of stroke: case-crossover analysis of continuously recorded heart rhythm from cardiac electronic implanted devices. Circ Arrhythmia Electrophysiol. 2015;8(5):1040–1047. doi:10.1161/CIRCEP.114.003057.
   PubMed Web of Science ®Google Scholar
• Boriani G, Botto GL, Padeletti L, et al. Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring. Stroke. 2011;42(6):1768–1770. doi:10.1161/STROKEAHA.110.609297.
   PubMed Web of Science ®Google Scholar
• Proietti R, Hadjis A, AlTurki A, et al. A systematic review on the progression of paroxysmal to persistent atrial fibrillation shedding new light on the effects of catheter ablation. JACC Clin Electrophysiol. 2015;1(3):105–115.
   PubMedGoogle Scholar
• Kornej J, Lip GYH, Bollmann A. Reduction of stroke and mortality in patients with atrial fibrillation by catheter ablation? Finally, tackling the hard endpoints. Europace. 2013;15(5):620–622. doi:10.1093/europace/eus389.
   PubMed Web of Science ®Google Scholar
• Lin Y-J, Chao T-F, Tsao H-M, et al. Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher. Europace Eur Pacing Arrhythmias Card Electrophysiol J Work Groups Card Pacing Arrhythmias Card Cell Electrophysiol Eur Soc Cardiol. 2013;15(5):676–684. doi:10.1093/europace/eus336.
   Google Scholar
• Zuern CS, Kilias A, Berlitz P, et al. Anticoagulation after catheter ablation of atrial fibrillation guided by implantable cardiac monitors. Pacing Clin Electrophysiol. 2015;38(6):688–693. doi:10.1111/pace.12625.
   PubMed Web of Science ®Google Scholar
• Wolsk E, Lamberts M, Hansen ML, et al. Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: a nationwide cohort study. Eur J Heart Fail. 2015;17(8):828–836. doi:10.1002/ejhf.309.
   PubMed Web of Science ®Google Scholar
• Melgaard L, Gorst-Rasmussen A, Lane DA, et al. Assessment of the CHA2DS2-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation. JAMA. 2015;314(10):1030–1038. doi:10.1001/jama.2015.10725.
   PubMed Web of Science ®Google Scholar
• ELAT study group. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med. 1998;128(8):639–647.
   PubMed Web of Science ®Google Scholar
• Hirsh BJ, Copeland-Halperin RS, Halperin JL. Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences. J Am Coll Cardiol. 2015;65(20):2239–2251. doi:10.1016/j.jacc.2015.03.557.
   PubMed Web of Science ®Google Scholar
• Daccarett M, Badger TJ, Akoum N, et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol. 2011;57(7):831–838. doi:10.1016/j.jacc.2010.09.049.
   PubMed Web of Science ®Google Scholar